LIMKi 3 is a potent, and cell-permeable inhibitor of LIMK1 (IC₅₀ = 7 nM) and LIMK2 (IC₅₀ = 8 nM) and inhibits coflin phosphorylation in MDA-MB-231 breast cancer cells without affecting tubulin polymerization or inducing cytotoxicity. It also reduces

Numéro d'article : BIOVB1095-25

Unité de mesure : 25 MG

625.00 CHF 625.0 CHF 625.00 CHF

625.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Fabricant : BIOVISION

Numéro du fabricant : B1095-25

Température de stockage : Freezer (-20)

LIMKi 3 is a potent, and cell-permeable inhibitor of LIMK1 (IC₅₀ = 7 nM) and LIMK2 (IC₅₀ = 8 nM) and inhibits coflin phosphorylation in MDA-MB-231 breast cancer cells without affecting tubulin polymerization or inducing cytotoxicity. It also reduces

LIMKi 3 is a potent, and cell-permeable inhibitor of LIMK1 (IC₅₀ = 7 nM) and LIMK2 (IC₅₀ = 8 nM) and inhibits coflin phosphorylation in MDA-MB-231 breast cancer cells without affecting tubulin polymerization or inducing cytotoxicity. It also reduces

625.00 CHF 625.0 CHF 625.00 CHF

625.00 CHF

Not Available For Sale